Copertina

Bacterial surface derived extracellular vesicles: A ground‐breaking approach in cancer therapy

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Asmit Das, Swarup Sonar, Ketki Kalele, Vetriselvan Subramaniyan
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	Clinical and Translational Discovery
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Milk exosomes: Harnessing nature's duality for cancer therapy
di: Asmit Das, et al.
Pubblicazione: (2024)

Clinical signature of exosomal tetraspanin proteins in cancer
di: Asmit Das, et al.
Pubblicazione: (2024)

Tumor and cancer stem cells‐derived exosomes interplay: A secret of cancer complications
di: Swarup Sonar, et al.
Pubblicazione: (2024)

Nanomedicine: a frontier of the breast cancer treatment
di: Swarup Sonar, et al.
Pubblicazione: (2024)

Role of DNA methylation in cancer development and its clinical applications
di: Swarup Sonar, et al.
Pubblicazione: (2024)

The prospective trajectory of exosomes‐based cancer nanomedicine
di: Divya Mirgh, et al.
Pubblicazione: (2024)

Plant exosomes: A natural medicine for oral cancer
di: Sidhanti Nyahatkar, et al.
Pubblicazione: (2024)

Clinical trial status of exosomes‐based cancer theranostics
di: Swarup Sonar
Pubblicazione: (2024)

Plant‐derived exosomes: A Green Nanomedicine for Cancer
di: Swarup Sonar, et al.
Pubblicazione: (2024)

Signature of click chemistry in exosome modification for cancer therapeutic
di: Nobendu Mukerjee, et al.
Pubblicazione: (2024)

High‐fat diet effects on brain mitochondrial complex I activity and protein lipoxidation: implications for translational medicine
di: Vetriselvan Subramaniyan, et al.
Pubblicazione: (2024)

Periodontitis and extracellular vesicles: Emerging roles in inflammation, tissue destruction and systemic crosstalk
di: Mai Ahmed, et al.
Pubblicazione: (2026)

Plant‐derived exosomes: A new frontier in nano‐medicine for cancer and microbial infection therapy
di: Swastika Maitra, et al.
Pubblicazione: (2024)

Sticky situation, strategic strike: Targeting neutrophil extracellular trap‐work in cancer
di: Bo Cao, et al.
Pubblicazione: (2025)

Engineered cell versus modified exosomes in cancer therapy
di: Rajib Dhar, et al.
Pubblicazione: (2024)

Liquid biopsy—A biomarker‐based revolutionising technique in cancer therapy
di: Subham Sarkar, et al.
Pubblicazione: (2024)

Effects of microRNA on the growth and targeted therapy response on lung cancer
di: Mengchen Zhu, et al.
Pubblicazione: (2024)

Modified plant‐derived exosomes: Precision medicine in cancer treatment
di: Swastika Maitra, et al.
Pubblicazione: (2024)

Targeting autophagy: A promising approach for the treatment of breast cancer brain metastases
di: Steffan T. Nawrocki, et al.
Pubblicazione: (2024)

scICB: A pan‐cancer database of human temporal immune checkpoint blockade therapy at single‐cell transcriptomic resolution
di: Fansen Ji, et al.
Pubblicazione: (2025)

Surufatinib plus anti‐PD‐1/PD‐L1 antibody as second‐line therapy for advanced biliary tract cancer: A single‐centre investigator‐initiated trial
di: Xinni Chen, et al.
Pubblicazione: (2026)

Toward precision oncology: An integrative multi‐omics approach for prognosis prediction and inferred immunotherapy responsiveness in breast cancer
di: Houda Bendani, et al.
Pubblicazione: (2026)

Challenges and advances of immune checkpoint therapy
di: Lingyu Li, et al.
Pubblicazione: (2024)

Targeting mutated KRAS in the first‐line therapy
di: Hideaki Ijichi
Pubblicazione: (2024)

Overcoming challenges in CAR‐T therapy for malignancies: Mechanisms and strategies
di: Yushan Huang, et al.
Pubblicazione: (2026)

Translational inhalable extracellular vesicle‐based mRNA therapy for the treatment of lung cancer
di: Mengrui Liu, et al.
Pubblicazione: (2025)

EccDNA, STING activation, and their potential roles in DLBCL prognosis and therapy
di: Xi‐Bo Hu, et al.
Pubblicazione: (2024)

The SLC39A1‐DRP1 axis: A paradigm shift in targeting mitochondrial dynamics for HCC therapy
di: Jing Zhao, et al.
Pubblicazione: (2025)

Mesenchymal stem cell therapy for ulcerative colitis: Opportunities and challenges in precision medicine
di: Peng‐Fei Wang, et al.
Pubblicazione: (2025)

CRISPR‐based gene therapy for wet age‐related macular degeneration in mouse model
di: Dongchun Xie, et al.
Pubblicazione: (2024)

Spatial omics accelerate the study of cancer‐associated fibroblasts in non‐small lung cancer
di: Haozhen Liu, et al.
Pubblicazione: (2024)

Sculpting nursing resilience: Transforming lives, nurturing ethics in chimeric antigen receptor T‐cell therapy
di: Pranay Bende
Pubblicazione: (2024)

Sweat exosomes: A new cutting edge nanomedicine in cancer treatment
di: Bikram Dhara, et al.
Pubblicazione: (2024)

Exploring new frontiers in lung cancer treatment: The role of cancer‐associated fibroblasts (CAFs) and EGFR‐TKI resistance
di: Jiaqi Liang, et al.
Pubblicazione: (2025)

Clinical and translational research on cancer of the stomach and gastroesophageal junction: A pathologist's view
di: Christoph Röcken
Pubblicazione: (2024)

Investigating the biological effects of socioeconomic adversity in cancer
di: David Füller
Pubblicazione: (2024)

Stereo cell: A new approach to the next generation of clinical precision medicine
di: Wanxin Duan, et al.
Pubblicazione: (2025)

Intravital microscopy contribution to cancer: From preclinical to human studies
di: Diogo Moniz‐Garcia, et al.
Pubblicazione: (2025)

Gastric cancer detection based on cell‐free DNA in blood: A systematic review and meta‐analysis
di: Mona Wang, et al.
Pubblicazione: (2024)

Tracking down metabolic vulnerabilities in CDK12‐mutant prostate cancer
di: Wei‐Ling Tu, et al.
Pubblicazione: (2024)